Angels for Change and STAQ Pharma expand Project PROTECT to supply five critical meds, tackling drug shortages and protecting patient care.

Explore medication options for kidney disease and potential side effects. Learn the best treatment options to slow ...

Shares of Cipla Ltd. opened with gains of as much as 5% on Friday, after the drugmaker announced that it has received final approval from the US Food and Drug Administration (USFDA) for its ...

For decades, thousands of women were given a controversial drug during their pregnancies with the hope of preventing miscarriage. The drug, called Diethylstilbestrol – commonly known as DES ...

Drug major Cipla on Friday said it has received approval from the US health regulator to market a generic cancer treatment drug. The company has received the final approval from the US Food and ...

Cipla receives USFDA approval for its generic cancer treatment drug, paclitaxel protein-bound particles, a therapeutic equivalent to Bristol Myers Squibb's Abraxane. The drug is expected to launch in ...

NEW DELHI, Apr 11: Drug major Cipla on Friday said it has received approval from the US health regulator to market a generic cancer treatment drug. The company has received the final approval from the ...

Federal parties have pitched different approaches to dealing with the toxic drug crisis in B.C. — particularly when it comes to overdose prevention and supervised consumption sites.

Senator John Fetterman revealed Tuesday in a piece he penned in The New York Times that he has been using the popular weight loss drug, Mounjaro. He wrote that the drug helped him “feel like ...

Wegovy and Zepbound are just the latest drug dyads to face-off in the competitive pharma market, continuing a legacy of rivalry that includes blockbuster drugs Keytruda, Humira and Eliquis. Obesity is ...

Natco Pharma on April 8 said that the launch of its generic version of Roche Pharma's patented drug, Risdiplam, is contingent upon the successful outcome in a patent infringement case. The ...

Experimental drug NU-9 -- a small molecule compound approved by the U.S. Food and Drug Administration (FDA) for clinical trials for the treatment of amyotrophic lateral sclerosis (ALS ...